Baek, Seungjin
Ahn, Seong Hee
Hong, Namki
Seo, Da Hea
Hong, Seongbin
Rhee, Yumie https://orcid.org/0000-0003-4227-5638
Funding for this research was provided by:
dongkook pharmaceutical Co., Ltd.
Article History
Received: 9 September 2024
Accepted: 12 November 2024
First Online: 26 November 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Yonsei University College of Medicine Ethics Committee and the Institutional Review Board and Ethics Committee of Inha University Hospital approved the study protocol (IRB No. 2021–01-018).
: Informed consent was obtained from all individual participants included in the study.
: Y.R. has received speaker honoraria from Amgen. Y.R. has been an investigator for Amgen, KyowaKirin, Hanmi, Dongkook, DONGAST, and Daewoong. All others declare that they have no conflict of interest.